Effects of temporarily suspending low-dose methotrexate treatment for 2 weeks after SARS-CoV-2 vaccine booster on vaccine response in immunosuppressed adults with inflammatory cond... by Abhishek, A, Boyton, RJ, McKnight, A, Coates, L, Barber, V, Francis, E, Appelbe, D, Julier, P, Eldridge, L, Cureton, L, Peckham, N, Cook, J

BpOmpW antigen stimulates the necessary protective T-cell responses against melioidosis by Tomás-Cortázar, J, Bossi, L, Quinn, C, Reynolds, CJ, Butler, DK, Corcoran, N, Murchú, MÓ, McMahon, E, Singh, M, Rongkard, P, Anguita, J, Blanco, A, Dunachie, SJ, Altmann, D, Boyton, RJ, Arnold, J, Giltaire, S, McClean, S

Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a ra... by Abhishek, A, Boyton, RJ, Peckham, N, McKnight, Á, Coates, LC, Bluett, J, Barber, V, Cureton, L, Francis, A, Appelbe, D, Eldridge, L, Julier, P, Valdes, AM, Brooks, T, Rombach, I, Altmann, DM, Nguyen-Van-Tam, JS, Williams, HC, Cook, JA

Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a ra... by Abhishek, A, Boyton, RJ, Peckham, N, McKnight, Á, Coates, LC, Bluett, J, Barber, V, Cureton, L, Francis, A, Appelbe, D, Eldridge, L, Julier, P, Valdes, AM, Brooks, T, Rombach, I, Altmann, DM, Nguyen-Van-Tam, JS, Williams, HC, Cook, JA

Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label,... by Abhishek, A, Peckham, N, Pade, C, Gibbons, JM, Cureton, L, Francis, A, Barber, V, Williams, J, Appelbe, D, Eldridge, L, Julier, P, Altmann, DM, Bluett, J, Brooks, T, Coates, LC, Rombach, I, Semper, A, Otter, A, Valdes, AM, Nguyen-Van-Tam, JS, Williams, HC, Boyton, RJ, McKnight, Á, Cook, JA

Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label,... by Abhishek, A, Peckham, N, Pade, C, Gibbons, JM, Cureton, L, Francis, A, Barber, V, Williams, JAE, Appelbe, D, Eldridge, L, Julier, P, Altmann, DM, Bluett, J, Brooks, T, Coates, LC, Rombach, I, Semper, A, Otter, A, Valdes, AM, Nguyen-Van-Tam, JS, Williams, HC, Boyton, RJ, McKnight, Á, Cook, JA

Antibody responses to Influenza vaccination are diminished in patients with inflammatory bowel disease on infliximab or tofacitinib by Liu, Z, Alexander, JL, Eng, KY, Ibraheim, H, Anandabaskaran, S, Saifuddin, A, Constable, L, Seoane, RC, Bewshea, C, Nice, R, D'Mello, A, Jones, GR, Balarajah, S, Fiorentino, F, Sebastian, S, Irving, PM, Hicks, LC, Williams, HRT, Kent, AJ, Linger, R, Parkes, M, Kok, K, Patel, KV, Teare, JP, Altmann, DM, Boyton, RJ, Hart, AL, Lees, CW, Goodhand, JR, Kennedy, NA, Pollock, KM, Ahmad, T, Powell, N